Brief: Prokidney Corp Reports Q3 Loss Of $0.13 Per Share
Nov 14 (Reuters) - Prokidney Corp PROK.O :
* PROKIDNEY REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
RECENT CORPORATE HIGHLIGHTS
* CASH AND CASH EQUIVALENTS AS OF SEPTEMBER 30, 2022, WAS
$506.3
MILLION
* QTRLY LOSS PER SHARE $0.13
* Q3 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA
* ANTICIPATE BEGINNING ENROLLMENT IN Q1 OF 2023 FOR PROACT 2
GLOBAL PHASE 3 STUDY
Source text for Eikon: ID:nGNXbG46qS
Further company coverage: PROK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prokidney
See all newsProkidney Corp reports results for the quarter ended September 30 - Earnings Summary
ProKidney Q3 loss widens on higher R&D costs
Brief: ProKidney Q3 Operating Income USD -53.758 Million
Brief: Prokidney Corp Enters Open Market Sale Agreement With Jefferies
Cell therapy developer ProKidney's Q2 operating loss widens as trial costs rise